Bicycle Therapeutics (BCYC) Interest Coverage Ratio (QoQ) (2018 - 2026)
Bicycle Therapeutics (BCYC) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.80% |
| Dec 31, 2025 | -1,935.41% |
| Sep 30, 2025 | 34.69% |
| Jun 30, 2025 | -54.15% |
| Mar 31, 2025 | 61.80% |
| Dec 31, 2024 | -3,657.64% |
| Sep 30, 2024 | 2.87% |
| Jun 30, 2024 | -194.45% |
| Mar 31, 2024 | 99.71% |
| Dec 31, 2023 | -10,104.62% |
| Sep 30, 2023 | -112.01% |
| Jun 30, 2023 | 32.44% |
| Mar 31, 2023 | 98.98% |
| Dec 31, 2022 | -17,073.48% |
| Sep 30, 2022 | 53.75% |
| Jun 30, 2022 | 95.59% |
| Mar 31, 2022 | -52.30% |
| Dec 31, 2021 | -19,479.15% |
| Sep 30, 2021 | 47.90% |
| Jun 30, 2021 | 99.30% |